|Stock Name : Divi’s Lab /Tips Open||Buy : 3,185.90||Posted Date : Aug 20, 2020|
|Stopless/Horizon : 3010||Target : 3330||Results Achieved (Yes/No) :|
Overview: Divi’s Laboratories Limited is a Large Cap company with a market capital of Rs 83130.16 Crore engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates.
About the company: Divi’s Laboratories Ltd was first established as Divi’s Research Center (DRC) in the year 1990 and later in 1994, they changed their name to Divi’s Laboratories limited. Divi develops carotenoids including Apocarotenal, Beta carotene, Lycopene, Astaxanthin and Canthaxanthin. They also manufacture tert-butoxycarbonyl (BOC), Fluoreny lmethyloxy carbonyl (FMOC) and Carboxy benzyl (CBZ) protected amino acids.
Divi’s is among the largest pharmaceutical companies in India with a portfolio of 120 products.
The company has four manufacturing and research and development facilities located in Andhra Pradesh and Telangana and market presence across several countries. Divi’s Laboratories limited has two subsidiaries, Divi’s Laboratories (USA) Inc. is in the United States of America and M/s. Divi’s Laboratories Europe AG is in the Switzerland.
Divi’s Laboratories Limited continues to be the largest API manufacturer in the world with a product list that includes 30 APIs which are manufactured commercially in 10’s to 100’s/1000’s of Tonnes each year, supplying to customers in more than 95 countries.
The company has a total of 11,000 employees across 3 countries out of which over 1700 employees are working in Quality Assurance & Quality Control functions. Divi has 350 scientists working in their R&D centres.
Management: Dr. Murali K Divi is the Founder and Managing Director of Divi’s Laboratories Ltd and Dr. Kiran Divi is the Chief Executive Officer.
• Promoters: 51.97%
• Foreign Institutions: 18.17%
• Mutual Funds: 15.57%
• Others: 4.48%
• General Public: 8.59%
• Financial Institutions: 1.23%
Dividend: Divi’s Laboratories has declared an equity dividend of 800.00% amounting to Rs 16 per share for the year ending March 2020.
Sales Report: Divi reported a consolidated sale of Rs 1730.47 Crore (for the quarter ended on 30th June 2020), which is up by 24.52 % from last quarter sales of Rs 1389.71 Crore and up by 48.81 % from last year same quarter sales of Rs 1162.88 Crore. Quarterly Net Profit of the company is Rs. 492.06 crore which is up by 80.61% from the year-ago same period profit of Rs 272.44 crore.
If you find any mistake please contact the firstname.lastname@example.org. This article is general in nature. It does not constitute a recommendation to buy and sell any stock, and does not take account of your objectives, or your financial situation. Largecapindia has no position in the stocks mentioned.
Largecapindia aim to bring you long term focused research analysis driven by fundamental thanks you.
For More Info : https://www.largecapindia.com